scholarly journals Evolution of chemokine receptors is driven by mutations in the sodium binding site

2018 ◽  
Vol 14 (6) ◽  
pp. e1006209 ◽  
Author(s):  
Bruck Taddese ◽  
Madeline Deniaud ◽  
Antoine Garnier ◽  
Asma Tiss ◽  
Hajer Guissouma ◽  
...  
2021 ◽  
Vol 22 (7) ◽  
pp. 3572
Author(s):  
Jeff Abramson ◽  
Ernest M. Wright

Active transport of sugars into bacteria occurs through symporters driven by ion gradients. LacY is the most well-studied proton sugar symporter, whereas vSGLT is the most characterized sodium sugar symporter. These are members of the major facilitator (MFS) and the amino acid-Polyamine organocation (APS) transporter superfamilies. While there is no structural homology between these transporters, they operate by a similar mechanism. They are nano-machines driven by their respective ion electrochemical potential gradients across the membrane. LacY has 12 transmembrane helices (TMs) organized in two 6-TM bundles, each containing two 3-helix TM repeats. vSGLT has a core structure of 10 TM helices organized in two inverted repeats (TM 1–5 and TM 6–10). In each case, a single sugar is bound in a central cavity and sugar selectivity is determined by hydrogen- and hydrophobic- bonding with side chains in the binding site. In vSGLT, the sodium-binding site is formed through coordination with carbonyl- and hydroxyl-oxygens from neighboring side chains, whereas in LacY the proton (H3O+) site is thought to be a single glutamate residue (Glu325). The remaining challenge for both transporters is to determine how ion electrochemical potential gradients drive uphill sugar transport.


2008 ◽  
Vol 74 (5) ◽  
pp. 1193-1202 ◽  
Author(s):  
David J. Nicholls ◽  
Nick P. Tomkinson ◽  
Katherine E. Wiley ◽  
Anne Brammall ◽  
Lorna Bowers ◽  
...  

2017 ◽  
Vol 112 (3) ◽  
pp. 114a
Author(s):  
Katherine E. Huffer ◽  
Andrés Jara-Oseguera ◽  
Kenton J. Swartz
Keyword(s):  

2020 ◽  
Vol 12 (13) ◽  
pp. 1213-1225 ◽  
Author(s):  
Shristi Pawnikar ◽  
Yinglong Miao

Background: Chemokine GPCRs play key roles in biology and medicine. Particularly, CXCR4 promotes cancer metastasis and facilitate HIV entry into host cells. Plerixafor (PLX) is a CXCR4 drug, but the pathway and binding site of PLX in CXCR4 remain unknown. Results & methodology: We have performed molecular docking and all-atom simulations using Gaussian accelerated molecular dynamics (GaMD), which are consistent with previous mutation experiments, suggesting that PLX binds to the orthosteric site of CXCR4 as an antagonist. The GaMD simulations further revealed an intermediate allosteric binding site at the extracellular mouth of CXCR4. Conclusion: The newly identified allosteric site can be targeted for novel drug design targeting CXCR4 and other chemokine receptors.


2014 ◽  
Vol 70 (a1) ◽  
pp. C1491-C1491
Author(s):  
Albert Guskov ◽  
Sonja Jensen ◽  
Stephan Rempel ◽  
Inga Hänelt ◽  
Dirk Slotboom

Archaeal homologues of human neuronal glutamate transporter catalyze the coupled uptake of aspartate and three sodium ions. After the delivery of the substrate and sodium ions in the cytoplasm the empty binding site must reorient to the outward-facing conformation to reset the transporter. Here we present a crystal structure of the substrate-free transporter GltTk from Thermococcus kodakarensis, resolved at 3 Å resolution [1]. Despite the global similarity to the previously resolved structures of aspartate transporter GltPh, there are tremendous rearrangements in the substrate-binding site. The key binding residue Arg401 moves in and partially occupies the substrate's position, while the rotation of another conserved residue Met314 completely destroys the geometry of the sodium-binding sites. This structure provides direct structural insight in the mechanism of the essential reorientation step in the translocation cycle for this type of transporters.


2000 ◽  
Vol 74 (23) ◽  
pp. 11008-11016 ◽  
Author(s):  
Susan E. Malenbaum ◽  
David Yang ◽  
Lisa Cavacini ◽  
Marshall Posner ◽  
James Robinson ◽  
...  

ABSTRACT We investigated the underlying mechanism by which the highly conserved N-terminal V3 loop glycan of gp120 conferred resistance to neutralization of human immunodeficiency virus type 1 (HIV-1). We find that the presence or absence of this V3 glycan on clade A and B viruses accorded various degrees of susceptibility to neutralization by antibodies to the CD4 binding site, CD4-induced epitopes, and chemokine receptors. Our data suggest that this carbohydrate moiety on gp120 blocks access to the binding site for CD4 and modulates the chemokine receptor binding site of phenotypically diverse clade A and clade B isolates. Its presence also contributes to the masking of CD4-induced epitopes on clade B envelopes. These findings reveal a common mechanism by which diverse HIV-1 isolates escape immune recognition. Furthermore, the observation that conserved functional epitopes of HIV-1 are more exposed on V3 glycan-deficient envelope glycoproteins provides a basis for exploring the use of these envelopes as vaccine components.


Sign in / Sign up

Export Citation Format

Share Document